JPRN-jRCT1080222572已完成Unknown
Special Drug Use-Results Survey of Onoact [tachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunction]
ONO PHARMACEUTICAL CO., LTD.0 个研究点目标入组 800 人开始时间: 2014年8月4日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with tachyarrhythmia, atrial fibrillation/atrial flutter under cardiac dysfunction for whom Onoact is administered
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
General Drug Use-Results Survey of Onoact [ ventricular fibrillation and hemodynamically ventricular tachycardia]Ventricular arrhythmiasJPRN-jRCT1080225340ONO PHARMACEUTICAL CO., LTD.200
进行中（未招募）
不适用
43-301 : Special Drug Use-Results Survey of ONGENTYSParkinson's diseaseJPRN-jRCT2011210013Kuro Toshihiko250
已完成
不适用
A Study of TAK-660 in surgical procedures for people with hemophilia AHemophilia AJPRN-jRCT2031210173Contact for Clinical Trial Information17
招募中
Unknown
Special Drug Use-Results Survey (All-Case Surveillance) to Investigate Safety and Effectiveness in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Empaveli in the Post-Marketing Clinical Use in JapaParoxysmal nocturnal hemoglobinuriaJPRN-jRCT2031230275Shimmoto Naoki100
招募中
不适用
Special Drug Use Results Survey for the use of Symtuza in pregnant womeJPRN-UMIN000037488Janssen Pharmaceutical K.K.3